Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.

Sanders S, Bartee D, Harrison MJ, Phillips PD, Koppisch AT, Freel Meyers CL. Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. PLoS One. 2018; 13(5):e0197638.

View in: PubMed

subject areas

Aldose-Ketose Isomerases
Anti-Bacterial Agents
Bacillus thuringiensis
Culture Media
Drug Interactions
Enterobacteriaceae
Erythritol
Escherichia coli Proteins
Fosfomycin
Metabolic Networks and Pathways
Microbial Sensitivity Tests
Multienzyme Complexes
Terpenes
Transferases

authors with profiles

Andrew Koppisch

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support